Literature DB >> 21989209

The population structure of drug-resistant Mycobacterium tuberculosis clinical isolates from Sichuan in China.

Yuding Zhao1, Qin Feng, Ke Tang, Congcong Zhang, Honghu Sun, Tao Luo, Zhirong Yang, David Couvin, Nalin Rastogi, Qun Sun.   

Abstract

China ranks second next to India among 22 high-burden countries despite decades' effort on tuberculosis (TB) control. The Sichuan province today contains the second-largest number of TB cases among Chinese provinces, where the prevalence of drug-resistant TB, especially MDR-TB, is much higher than the average level in eastern China. In this study, the population structure and the transmission characteristics of drug-resistant TB in Sichuan province were studied by spoligotyping and 24-locus Mycobacterial interspersed repetitive units-variable number tandem DNA repeats (MIRU-VNTR), applied to a total of 306 clinical isolates. Spoligotyping-based analysis showed that Beijing family represented 69.28% of all isolates and constituted the largest group (66.24%) of MDR-TB in Sichuan. The remaining isolates, accounting for 33.76% of MDR isolates, belonged to the ill-defined T family, Manu2, H3, LAM9, and other minor unassigned clades. The discriminatory power evaluated for spoligotyping was poor (HGI=0.595), but high for 24-locus MIRU-VNTRs (HGI=0.999). The number of the most discriminatory loci (h>0.6) was 12, including locus 424, 802, 960, 1644, 1955, 2163b, 2996, 3007, 3192, 3690, 4348 and 4052. It was concluded that 24-locus MIRU-VNTRs could be a more discriminatory tool for differentiating clinical isolates from Sichuan region. The small clustering size obtained from the current population structure analysis suggested that the high prevalence of drug-resistant TB in this region might be attributed partially to the acquired resistance due to inappropriate drug use rather than active transmission of drug-resistant TB (primary resistance).
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21989209     DOI: 10.1016/j.meegid.2011.09.022

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  10 in total

1.  Mixed Infections and Rifampin Heteroresistance among Mycobacterium tuberculosis Clinical Isolates.

Authors:  Chao Zheng; Song Li; Zhongyue Luo; Rui Pi; Honghu Sun; Qingxia He; Ke Tang; Mei Luo; Yuqing Li; David Couvin; Nalin Rastogi; Qun Sun
Journal:  J Clin Microbiol       Date:  2015-04-22       Impact factor: 5.948

2.  Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China.

Authors:  Yu Pang; Yang Zhou; Bing Zhao; Guan Liu; Guanglu Jiang; Hui Xia; Yuanyuan Song; Yuanyuan Shang; Shengfen Wang; Yan-lin Zhao
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

3.  The burden of MDR/XDR tuberculosis in coastal plains population of China.

Authors:  Xiujun Yang; Yanli Yuan; Yu Pang; Bo Wang; Yunlong Bai; Yanhua Wang; Baozhu Yu; Zhiying Zhang; Ming Fan; Yanlin Zhao
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

4.  Clinical Features and Drug-Resistance Profile of Urinary Tuberculosis in South-Western China: A Cross-sectional Study.

Authors:  Yuanxin Ye; Xuejiao Hu; Yunying Shi; Juan Zhou; Yi Zhou; Xingbo Song; Yi Xie; Xiaojun Lu; Lanlan Wang; Binwu Ying; Xuerong Chen
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

5.  A First Insight into the Genetic Diversity and Drug Susceptibility Pattern of Mycobacterium tuberculosis Complex in Zhejiang, China.

Authors:  Zhengwei Liu; Yu Pang; Songhua Chen; Beibei Wu; Haibo He; Aizhen Pan; Xiaomeng Wang
Journal:  Biomed Res Int       Date:  2016-11-22       Impact factor: 3.411

6.  High prevalence and low cure rate of tuberculosis among patients with HIV in Xinjiang, China.

Authors:  Rena Maimaiti; Yuexin Zhang; Kejun Pan; Peierdun Mijiti; Maimaitiali Wubili; Maimaitijiang Musa; Rune Andersson
Journal:  BMC Infect Dis       Date:  2017-01-05       Impact factor: 3.090

7.  Genetic diversity and drug resistance of Mycobacterium tuberculosis in Yunnan, China.

Authors:  Daoqun Li; Yuzhu Song; Pengpeng Yang; Xiaofei Li; A-Mei Zhang; Xueshan Xia
Journal:  J Clin Lab Anal       Date:  2019-03-21       Impact factor: 2.352

8.  Suitability of IS6110-RFLP and MIRU-VNTR for differentiating spoligotyped drug-resistant mycobacterium tuberculosis clinical isolates from Sichuan in China.

Authors:  Chao Zheng; Yuding Zhao; Guoqiang Zhu; Song Li; Honghu Sun; Qin Feng; Mei Luo; Fanzi Wu; Xuefeng Li; Véronique Hill; Nalin Rastogi; Qun Sun
Journal:  Biomed Res Int       Date:  2014-03-03       Impact factor: 3.411

9.  Development of a hierarchical variable-number tandem repeat typing scheme for Mycobacterium tuberculosis in China.

Authors:  Tao Luo; Chongguang Yang; Yu Pang; Yanlin Zhao; Jian Mei; Qian Gao
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

10.  Comparative study of RFLP-IS6110 and MIRU-VNTR from Mycobacterium tuberculosis isolated in the state of Minas Gerais, Brazil.

Authors:  Cláudio José Augusto; Wânia da Silva Carvalho; Isabela Neves de Almeida; Lida Jouca de Assis Figueiredo; Nayanne Gama Teixeira Dantas; Philip Noel Suffys; Silvana Spíndola de Miranda
Journal:  Braz J Microbiol       Date:  2017-12-11       Impact factor: 2.476

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.